Andes Biotechnologies Competitors and Similar CompaniesClear all
Andes Biotechnologies's competitors and similar companies include Cayman Chemical, CanSino Biologics, FibroGen and Innoprot.
 Andes Biotechnologies Andes Biotechnologies is a nucleic acid-based drug discovery and development company focused on solid tumor cancers. |  Cayman Chemical Cayman Chemical Company is a manufacturer and supplier of biochemicals, assay kits, antibodies, and recombinant proteins. |  CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  Innoprot Innoprot is a biotechnology company that provides products and technologies for cell-based assays in drug discovery and development. | |
Founding Date | Founding Date 2008 | Founding Date 1980 | Founding Date 2009 | Founding Date 1993 | Founding Date 2007 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Ñuñoa, CL HQ | Locations Ann Arbor, US HQ Neratovice, CZ Tallinn, EE State College, US | Locations Tianjin, CN HQ | Locations San Francisco, US HQ | Locations Derio, ES HQ |
Employees | Employees 5 | Employees 2725% decrease | Employees 1,10526% decrease | Employees 53115% increase | Employees 16 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥81.4m (FY, 2025) | Cost of goods $556k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥1.1b (FY, 2025) | Gross profit $5.9m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ¥27.9m (FY, 2025) | Net income $183.5m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.5m | Total funding raised $ 76m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Cayman Chemical
HQ
Ann Arbor, US
Employees
272↓ 5% decrease
Cayman Chemical Company is a manufacturer and supplier of biochemicals, assay kits, antibodies, and recombinant proteins.
View companyCanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View companyFibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View companyInnoprot
HQ
Derio, ES
Employees
16
Innoprot is a biotechnology company that provides products and technologies for cell-based assays in drug discovery and development.
View company